Composition for contraception
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 16, 2013
Grant Date -
N/A
app pub date -
Aug 28, 2007
filing date -
Dec 22, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
A combination product for oral contraception is disclosed comprising an estrogen selected from
- 2.0 to 6.0 mg of 17β-estradiol and0.020 mg of ethinylestradiol;and a gestagen selected from0.25 to 0.30 mg of drospirenone and0.1 to 0.2 mg of cyproterone acetate,followed by 5 or 4 pill-free or sugar pill days.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully